Literature DB >> 21198342

Rhinoscleroma: an updated experience through the last 10 years.

Hazem A Gaafar1, Alaa H Gaafar, Yasser A Nour.   

Abstract

CONCLUSION: Rhinoscleroma is a chronic, specific, granuloma of the nose and other parts of the respiratory system. The disease is endemic in Egypt and many other countries. The causative organism is Klebsiella rhinoscleromatis bacillus, proved by fulfilling Koch's postulates. The mode of infection is not known and its worldwide irregular geographical distribution is not understood. Lines of treatment are unsatisfactory and a tendency for recurrence is the rule.
OBJECTIVES: Our aim was to study the clinical presentation, microbiology, pathological staging, follow-up, and lines of treatment of new rhinoscleroma patients admitted or seen at Alexandria Main University Hospital from January 1999 until January 2009.
METHODS: Demographic data and the results of clinical, bacteriological, and histological examinations were reviewed. Medical and surgical treatments were evaluated. Follow-up as regards the results of treatment and incidence of recurrence was assessed.
RESULTS: Fifty-six patients were included in the study. There were 26 males and 30 females, and 85% of patients presented in the third and fourth decades of life. The nose was affected in 100% of patients. Other regions affected were the nasopharynx in 13 patients, palate in 7 patients, skin in 2 patients, larynx in 3 patients, trachea in 17 patients, nasolacrimal duct in 2 patients, and premaxilla in 1 patient. No lymph node affection was reported. Klebsiella rhinoscleromatis strain III was isolated from 100% of patients. Antibiotics used were a combination of trimethoprim-sulfamethoxazole 400 mg and rifampicin 300 mg twice daily for 3 months. Since 2003, this was replaced by ciprofloxacin 500 mg twice daily for 3 months. Surgical procedures performed were removal of nasal granulations, bronchoscopic dilatation, bipolar coagulation of skin lesions, tracheostomy, and repair of pharyngeal stenosis. Results were disappointing, as a large number of patients did not attend for follow-up. A high incidence of recurrence was found, reaching up to 25% within 10 years.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21198342     DOI: 10.3109/00016489.2010.539264

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  12 in total

1.  Rhinoscleroma: a detailed histopathological diagnostic insight.

Authors:  Ahmed R H Ahmed; Zeinab H El-Badawy; Ibrahim R Mohamed; Waleed A M Abdelhameed
Journal:  Int J Clin Exp Pathol       Date:  2015-07-01

2.  Role of Histopathology in Differentiating Primary Atrophic Rhinitis from Atrophic Stage of Rhinoscleroma.

Authors:  Umesh S Nagalotimath; Krishnamurthy Naveen; Rekha B Puranik; Dandinarasaiah Manjunath; Mahesh Venkatesha
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2017-01-12

3.  Unexpected pathologies in patients referred for endoscopic DCR.

Authors:  Shani Golan; Igal Leibovitch; Roee Landsberg
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-01-30       Impact factor: 2.503

4.  Airway management of an unusual case of recurrent rhinoscleroma.

Authors:  Nita D'souza; Shilpa Kulkarni; Shama Bhagwat; Rusi Marolia
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2011-07

5.  Rhinoscleroma presenting as a nasal-palatal mass with airway obstruction.

Authors:  Mark C Domanski; Alexander Rivero; David E Kardon
Journal:  F1000Res       Date:  2013-05-09

6.  Algorithmic Approach to Fibroinflammatory Sinonasal Tract Lesions.

Authors:  Lester D R Thompson
Journal:  Head Neck Pathol       Date:  2021-03-15

7.  A novel murine model of rhinoscleroma identifies Mikulicz cells, the disease signature, as IL-10 dependent derivatives of inflammatory monocytes.

Authors:  Cindy Fevre; Ana S Almeida; Solenne Taront; Thierry Pedron; Michel Huerre; Marie-Christine Prevost; Aurélie Kieusseian; Ana Cumano; Sylvain Brisse; Philippe J Sansonetti; Régis Tournebize
Journal:  EMBO Mol Med       Date:  2013-04       Impact factor: 12.137

8.  Rhinoscleroma with Pharyngolaryngeal Involvement Caused by Klebsiella ozaenae.

Authors:  J Gonzales Zamora; A R Murali
Journal:  Case Rep Infect Dis       Date:  2016-05-12

Review 9.  Orphan diseases of the nose and paranasal sinuses: Pathogenesis - clinic - therapy.

Authors:  Martin Laudien
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2015-12-22

10.  Rhinoscleroma pathogenesis: The type K3 capsule of Klebsiella rhinoscleromatis is a virulence factor not involved in Mikulicz cells formation.

Authors:  Barbara Corelli; Ana S Almeida; Fabiane Sonego; Virginia Castiglia; Cindy Fevre; Sylvain Brisse; Philippe J Sansonetti; Régis Tournebize
Journal:  PLoS Negl Trop Dis       Date:  2018-01-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.